GFAP and Alzheimer disease: Studies examining the role of blood GFAP in AD have so far all used Simoa technology using the Human GFAP Discovery Kit from Quanterix (Lexington, MA, USA) (Oeckl et al, 2019; Cicognola et al, 2021; Pereira et al, 2021a; Verberk et al, 2021).